Nasdaq
Vistin Pharma ASA : Annual Report for 2017
13-04-2018
Oslo, Norway, 13 April 2018
The Board of Directors of Vistin Pharma ASA has on 13 April 2018 approved the Directors' report and consolidated financial statements for Vistin Pharma for 2017. The annual report for 2017 is enclosed, and will be made available on www.vistin.com. There are no material changes in the financial statements, compared to the preliminary full year results presented on 27 February 2018.
For further information, please contact:
Gunnar Manum
CFO
+47 95 17 91 90
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
Attachment